Trials / Unknown
UnknownNCT00964457
Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients
Treatment of Patient With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before Under and After Radiation and With Adding Cetuximab to K_RAS Wild-type Patients.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Copenhagen University Hospital at Herlev · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
response rate to adding cetuximab, oxaliplatin and capecitabine to radiation for advanced rectum cancer
Detailed description
Dynamic MRI will be used to monitor the effect of the treatment and will be compared to pathologic results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cetuximab | cetuximab 500mg per meter square every second week |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2012-07-01
- Completion
- 2017-07-01
- First posted
- 2009-08-25
- Last updated
- 2009-08-25
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00964457. Inclusion in this directory is not an endorsement.